Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
Volume: 7, Issue: 5, Pages: 1 - 1
Published: Apr 22, 2020
Abstract
Younger patients with COVID-19 may experience an exaggerated immune response to SARS-CoV-2 infection and develop cytokine release syndrome (CRS), which may be life threatening. There is no proven antiviral therapy for COVID-19 so far, but profound immunosuppression has recently been suggested as a treatment for COVID-19-associated CRS. We present a case of life-threatening CRS caused by COVID-19 infection with a favourable response to...
Paper Details
Title
Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
Published Date
Apr 22, 2020
Volume
7
Issue
5
Pages
1 - 1
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History